Valuation: Medpace Holdings, Inc.

Market Cap 15.92B 13.92B 12.82B 11.89B 22.62B 1,519B 22.89B 153B 59.62B 745B 59.8B 58.49B 2,581B P/E 2026 *
33.2x
P/E 2027 * 30.4x
Enterprise Value 14.76B 12.89B 11.88B 11.02B 20.96B 1,407B 21.21B 142B 55.25B 691B 55.41B 54.2B 2,391B EV / Sales 2026 *
5.32x
EV / Sales 2027 * 4.85x
Free-Float
80.38%
Yield 2026 *
-
Yield 2027 * -
1 day+1.34%
1 week+7.21%
Current month+6.70%
1 month+24.40%
3 months+13.39%
6 months-3.70%
Current year+0.61%
1 week 523.69
Extreme 523.69
567.91
1 month 445
Extreme 445.005
567.91
Current year 373
Extreme 373
628.92
1 year 306.7
Extreme 306.7035
628.92
3 years 227.21
Extreme 227.21
628.92
5 years 126.94
Extreme 126.945
628.92
10 years 21.76
Extreme 21.76
628.92
Manager TitleAgeSince
Chief Executive Officer 69 1992-06-30
Director of Finance/CFO 51 2021-07-31
Chief Tech/Sci/R&D Officer 65 2017-08-31
Director TitleAgeSince
Chairman 69 1992-06-30
Director/Board Member 55 2016-06-30
Director/Board Member 72 2016-06-30
Date Insider Type Main position Quantity % Market Cap.
06-29Fiscal year

Director

56 0.0002%
06-29Fiscal year

Director

72 0.0003%
06-29Fiscal year

Director

66 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.34%+7.21%+75.77%+138.54% 15.92B
+1.08%+8.57%+3.61%+9.34% 49.92B
+0.40%+4.34%+401.69%+606.81% 40.23B
-0.52%+7.76%+25.41%-6.76% 34.55B
+3.97%+10.56%+26.06%+61.61% 33.09B
-4.19%+6.03%+3.76%+32.17% 27.51B
-2.40%+2.75% - - 17.05B
-0.95%-0.38%+12.92%+17.96% 13.86B
+1.69%+2.46%+93.44%+97.16% 13.52B
-4.52%+52.54%+1,733.57%+733.76% 13.31B
Average -0.41%+11.12%+264.02%+187.84% 25.9B
Weighted average by Cap. -0.01%+9.17%+181.50%+169.91%

Financials

2026 *2027 *
Net sales 2.77B 2.42B 2.23B 2.07B 3.94B 265B 3.99B 26.65B 10.39B 130B 10.42B 10.19B 450B 2.95B 2.58B 2.37B 2.2B 4.19B 281B 4.24B 28.31B 11.03B 138B 11.07B 10.82B 478B
Net income 492M 430M 396M 368M 699M 46.96B 708M 4.73B 1.84B 23.04B 1.85B 1.81B 79.79B 539M 471M 434M 403M 766M 51.43B 775M 5.18B 2.02B 25.24B 2.02B 1.98B 87.39B
Net Debt -1.17B -1.02B -941M -873M -1.66B -111B -1.68B -11.23B -4.38B -54.71B -4.39B -4.29B -189B -1.62B -1.41B -1.3B -1.21B -2.3B -154B -2.33B -15.54B -6.06B -75.72B -6.07B -5.94B -262B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,300
Date Price Change Volume
26-07-06 US$565.09 +1.34% 234,156
26-07-02 US$557.60 +2.58% 356,575
26-07-01 US$543.57 +2.64% 312,635
26-06-30 US$529.59 -0.96% 335,554
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
565.09USD
Average target price
443.50USD
Spread / Average Target
-21.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock